Mitochondrial diseases are a heterogeneous group of disorders in which
it has been suggested that genetic defects in oxidative phosphorylati
on lead to specific alterations in exercise performance and lactate me
tabolism during exercise. To investigate this possibility, we evaluate
d pulmonary function tests, incremental exercise testing, and serial b
lood lactate levels in a group of subjects with mitochondrial disease
(M) and compared them with a group of patients with nonmitochondrial (
N) myopathies and healthy subjects (H). The two groups were demographi
cally comparable and had no significant differences in pulmonary funct
ion. Both groups showed similar degrees of reduced exercise tolerance
compared with a group of healthy subjects (M: 61.08% predicted Vo(2)ma
x +/- 19.58 SD, n = 13; N: 62.14 +/- 28.89, n = 7; H: 115.17 +/- 19.35
, n = 12; p < 0.001). The mitochondrial disease group more frequently
showed abnormalities in cardiac response to exercise than did the nonm
itochondrial myopathy subjects (M: 12/13, N: 3/7, H: 3/12, p = 0.002).
Minute ventilation greater than predicted occurred with similar frequ
ency in both groups. Although resting lactate level was increased in s
ome subjects with mitochondrial myopathy compared with disease control
s, there were no differences between groups for peak venous lactate le
vel normalized for oxygen uptake or the rate of lactate clearance. The
se findings, while confirming the presence of some specific abnormalit
ies in mitochondrial disease, are against the notion that exercise lim
itation in this condition directly results from specific abnormalities
in oxidative metabolism.